New Hampton, NY—Balchem Company shared the information of its acquisition of main methylsulfonylmethane (MSM) producer Bergstrom Vitamin. Bergstrom will be a part of Balchem’s Human Vitamin and Well being enterprise division and the Minerals & Vitamins enterprise unit.
“We’re excited to welcome Bergstrom Vitamin to Balchem,” stated Ted Harris, Chairman, CEO and President of Balchem, in a launch. “Because the MSM market chief, Bergstrom Vitamin has excelled in advancing the science and presence of MSM globally. The addition of OptiMSM to our portfolio gives a synergistic scientific benefit in Balchem’s key strategic therapeutic focus areas reminiscent of longevity and efficiency and is a robust match with Balchem’s specialty, science-backed mineral merchandise. We sit up for increasing market alternatives collectively.”
Adrian Polliack, Bergstrom Vitamin President and CEO, added, “We’re very happy to affix such a top quality, scientifically pushed group as Balchem. OptiMSM aligns properly with Balchem’s already strong portfolio and enhances their strategic well being profit platforms. Becoming a member of Balchem permits for accelerated progress and market attain and we sit up for working along with the Balchem crew.”
Associated: M&A Replace: Vitamin K2 Firm to Be part of Balchem
Bergstrom Vitamin Welcomes New CEO
OptiMSM to Characteristic Knowledgeable-Ingredient Emblem
Bergstrom’s OptiMSM holds a GRAS classification. The addition of OptiMSM expands Balchem’s portfolio within the areas of longevity and efficiency, and is an efficient match with Balchem’s mineral merchandise, in keeping with the discharge.
